一份减持公告,轻松引发了一场股价暴跌。 3月17日,“猴茅”昭衍新药A+H股同时大跌,截至当日收盘,A股股价跌停,报收29.32元/股,股价创2026年以来新低;港股跌幅更大,收盘报16.78港元,较前一交易日跌幅达11.73%,盘中最低触及16.53港元,创近期区间新低。 这场暴跌的直接导火索是公司3月16日晚间披露的清仓式减持公告。股东顾晓磊及其一致行动人顾美芳(姑侄关系)计划未来3个月内...
Source Link一份减持公告,轻松引发了一场股价暴跌。 3月17日,“猴茅”昭衍新药A+H股同时大跌,截至当日收盘,A股股价跌停,报收29.32元/股,股价创2026年以来新低;港股跌幅更大,收盘报16.78港元,较前一交易日跌幅达11.73%,盘中最低触及16.53港元,创近期区间新低。 这场暴跌的直接导火索是公司3月16日晚间披露的清仓式减持公告。股东顾晓磊及其一致行动人顾美芳(姑侄关系)计划未来3个月内...
Source LinkDisclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.